期刊文献+

食管鳞癌全量放化疗后复发补救手术患者的生存期分析

Salvage esophagectomy for recurrent esophageal squamous cell carcinoma treated with definitive chemo-radiotherapy: long-term survival analysis
下载PDF
导出
摘要 目的评价食管鳞癌全量放化疗后复发补救性食管切除手术的临床价值及安全性,并分析影响预后的因素。方法收集58例食管鳞癌根治性放化疗后复发补救性食管切除手术患者的临床资料,回顾性分析手术方式、术后并发症、术后pTNM分期等参数对预后的影响。结果 58例患者均予右胸入路,经后纵隔食管床胃代食管重建消化道,行颈胸腹三切口颈部吻合术式43例,胸腹二切口胸内吻合15例。R0切除50例,R1切除8例。术后并发症发生率和住院死亡率分别为22.4%和3.4%。术后中位总生存期为59.9个月,5年生存率为49.3%。单因素及多因素分析显示,术后pT、pN分期为影响术后远期生存的危险因素。结论食管鳞癌全量放化疗后复发予以补救性食管切除手术的风险较高,但可延长生存。术后pT分期、pN分期可以为术后的生存预测提供参考。 Objective To evaluate the safety and value of salvage esophagectomy for locoregional recurrence after definitive chemo-radiotherapy for esophageal squamous cell carcinoma,and to explore the prognostic factors affecting long-term survival. Methods Fifty-eight consecutive patients with esophageal squamous cell carcinoma submitted to salvage esophagectomy for locoregional recurrent disease after primary exclusive chemoradiotherapy were retrospectively analyzed.The surgical procedures,postoperative complications,postoperative TNM staging,overall survival and the prognosis were reviewed. Results All the patients received right-transthoracic esophagectomy and reconstruction using gastric conduit by way of posterior-mediastinal route,with 3-field left cervical anastomosis(43 cases) or 2-field intra-thoracic anastomosis(15 cases).R0 resection was achieved in 50 cases,while R1 resection in 8 cases.Overall postoperative morbidity and mortality were 22.4% and 3.4%,respectively.The median survival was 59.9 months with a 5-year overall survival rate of 49.3%.Postoperative pathological T stage and N stage were independent prognostic factors in univariate and multivariate analysis. Conclusion Although associated with increased morbidity and mortality,salvage esophagectomy provides long-term survival benefit in esophageal squamous cell carcinoma patients with locoregional recurrent disease after primary definitive chemo-radiotherapy.Postoperative pathological T stage and N stage seem to be valuable for prognostic evaluation.
出处 《临床肿瘤学杂志》 CAS 2011年第12期1092-1095,共4页 Chinese Clinical Oncology
关键词 食管鳞癌 全量放化疗 补救性食管切除手术 Esophageal squamous cell carcinoma Definitive chemo-radiotherapy Salvage esophagectomy
  • 相关文献

参考文献10

  • 1陈万青.2004-2005年中国恶性肿瘤发病与死亡的估计[J].中华肿瘤杂志,2009,31(9):664-668. 被引量:136
  • 2Takeuchi H,Saikawa Y,Oyama T,et al.Factors intluencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy[J].World J of Surg,2010,34(2):277-284.
  • 3Pinto CE,de Souza Femandes D,Sá EA,et al.Salvage esophagectomy after exclusive chemoradiotherapy:results at the Brazilian National Cancer Institute (INCA)[J].Dis Esophagus,2009,22 (8):682-686.
  • 4陈龙奇.食管癌国际TNM分期第7版解读与评价[J].中华肿瘤杂志,2010,32(3):237-240. 被引量:115
  • 5Tachimori Y.Role of salvage esophagectomy after definitive chemoradiotherapy[J].Gen Thorac Cardiovasc Surg,2009,57(2):71-78.
  • 6Piessen G,Briez N,Triboulet JP,et al.Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy:who will benefit from surgery?[J].Ann Surg Oncol,2007,14(7):2036-2044.
  • 7Chao YK,Chan SC,Chang HK,et al.Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus[J].Eur J Surg Oncol,2009,35(3):289-294.
  • 8Tachimori Y,Kanamori N,Uemura N,et al.Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma[J].J Thorac Cardiovasc Surg,2009,137(1):49-54.
  • 9Meunier B,Raoul J,Le Prise E,et al.Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus[J].Dig Surg,1998,15:224-226.
  • 10Miyata H,Yamasaki M,Takiguchi S,et al.Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer[J].J Surg Oncol,2009,100(6):442-446.

二级参考文献28

  • 1全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.中国肿瘤登记年报(2004).北京:中国协和医科大学出版社,2008:10.
  • 2中华人民共和国卫生部.全国第三次死因回顾抽样调查报告.北京:中国协和医科大学出版社,2008:10.
  • 3Verdecchia A, De Angelis R, Francisci S, et al. Methodology for estimation of cancer incidence, survival and prevalence in Italian regions. Tumori, 2007, 93:337-344.
  • 4Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 2005, 14:243-250.
  • 5Igaki H,Tachimori Y,Kato H.Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection.Ann Surg,2004,239:483-490.
  • 6Fang WT,Chen WH,Chen Y,et al.Sdective three-field lymphadenectomy for thoracic esophageal squamous carcinoma.Dis Esophagus,2007.20:206-211.
  • 7Zhang HL,Chen LQ,Liu RL,et al.The number of lymph node metastases influences survival and Intemational Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.Dis Esophagus,2010,23:53-58.
  • 8Xiao ZF,Yang ZY,Miao YJ,et al.Influence of number of metastatic lymph nedes on survival of curative reacted thoracic esophageal cancer patients and value of radiotherapy:report of 549 cases.Int J Radiat Oncol Biol Phys,2005,62:82-90.
  • 9Mariette C,Piessen G,Briez N,et al.The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.Ann Surg,2008.247:365-371.
  • 100'Riordan JM,Rowley S,Murphy JO,et al.Impact of solitary involved lymph node on outcome in localized cancer of the esophagus and esophagogastric junction.J Gastrointest Surg,2007,11:493-499.

共引文献249

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部